Showing 6921-6930 of 9139 results for "".
- AI in Action: Perfect Corp. Debuts New Skin Type Detection Technologyhttps://practicaldermatology.com/news/ai-in-action-perfect-corp-debuts-new-skin-type-detection-technology/2461883/
- EMA to Review UCB’s Bimekizumab for HShttps://practicaldermatology.com/news/ema-to-review-ucbs-bimekizumab-for-hs/2461869/The European Medicines Agency (EMA) will reviww UCB’s marketing authorization application for bimekizumab for the treatment of adults with moderate to severe hidradenitis suppurativa (HS). Bimekizumab is an IL-17A and IL-17F inhibitor. The safety and efficacy of bim
- AD Pipeline Watch: Alphyn Biologics’ Topical AB-101Shows Promise in Phase 2a Studyhttps://practicaldermatology.com/news/ad-pipeline-watch-alphyn-biologics-topical-ab-101shows-promise-in-phase-2a-study/2461852/
- VisualDx, Vaseline Join Forces to Advance Education on Treating Skin of Colorhttps://practicaldermatology.com/news/visualdx-vaseline-join-forces-to-advance-education-on-treating-skin-of-color/2461817/VisualDx and
- Sol-Gel, Searchlight Pharma Partner to Commercialize TWYNEO and EPSOLAY in Canadahttps://practicaldermatology.com/news/sol-gel-searchlight-pharma-partner-to-commercialize-twyneo-and-epsolay-in-canada/2461764/Israel’s Sol-Gel Technologies, Ltd. and Searchlight Pharma Inc. have signed exclusive license agreements for TWYNEO and EPSOLAY for the Canadian market. Both products recently launched in the U.S., and Searchlight is to commercialize in Canada over a fifteen-year term that i
- And the Winners Are...Mary Kay, ESDR Announce New Grant Recipientshttps://practicaldermatology.com/news/and-the-winners-are-mary-kay-esdr-announce-new-grant-recipients/2461724/Mary Kay Inc. and
- Nielsen BioSciences, Maruho Co. Ltd. Enter License Agreement for the Treatment of Common Wartshttps://practicaldermatology.com/news/nielsen-biosciences-maruho-co-ltd-enter-license-agreement-for-the-treatment-of-common-warts/2461719/Nielsen BioSciences, Inc.</
- Positive Results Seen for Alphyn’s AB-101 in Kids with ADhttps://practicaldermatology.com/news/positive-pediatric-results-seen-for-alphyns-ab-101-in-ad/2461700/
- AI In Action: Rubedo Life Sciences Introduces RLS-1496 as a Potential First-in-Class Derm Drughttps://practicaldermatology.com/news/ai-in-action-rubedo-life-sciences-introduces-rls-1496-as-a-potential-first-in-class-derm-drug/2461699/Rubedo Life Sciences has nominated RL
- PathologyWatch Launches ‘Show Me Some Skin’ Campaign for Skin Cancer Awareness Monthhttps://practicaldermatology.com/news/pathologywatch-launches-show-me-some-skin-campaign-for-skin-cancer-awareness-month/2461696/